Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Cash from Operations (2023 - 2025)

Metagenomi (MGX) has disclosed Cash from Operations for 3 consecutive years, with 23546000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 10.39% to 23546000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 88892000.0, a 18.5% increase, with the full-year FY2025 number at 88892000.0, up 18.5% from a year prior.
  • Cash from Operations was 23546000.0 for Q4 2025 at Metagenomi, down from 21253000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 20592000.0 in Q4 2023 to a low of 29850000.0 in Q1 2024.
  • A 3-year average of 24114500.0 and a median of 23638000.0 in 2023 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 42.18% in 2024, then grew 23.48% in 2025.
  • Metagenomi's Cash from Operations stood at 20592000.0 in 2023, then fell by 27.6% to 26276000.0 in 2024, then increased by 10.39% to 23546000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Cash from Operations are 23546000.0 (Q4 2025), 21253000.0 (Q3 2025), and 21251000.0 (Q2 2025).